Teva appoints Dr. Tal Zaks to Board of Directors, effective Oct 1, 2021

TEVA PHARMACEUTICAL INDUSTRIES LTD

Dr. Tal Zaks elected to Teva Board, effective Oct 1, 2021, until 2022 annual meeting.
Zaks joins from Moderna where he was Chief Medical Officer; departs late Sept 2021.
Determined independent under NYSE rules; appointed to Science and Technology Committee.
Will receive same compensation as other non-executive directors (see 2020 proxy).
Zaks has MD/PhD, experience at Sanofi, Cephalon, GSK, and as adjunct professor at UPenn and Tufts.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Tal Zaks

Member of the Board

TEVA · TEVA PHARMACEUTICAL INDUSTRIES LTD

Effective: 2021-10-01
Filed: August 27, 2021, 7:59 PM ET

elected Dr. Tal Zaks to serve as a member of the Board, effective October 1, 2021

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Tal Zaks was elected as Member of the Board at TEVA PHARMACEUTICAL INDUSTRIES LTD.

Action: elected
Role: Member of the Board

Exact text from the filing

elected Dr. Tal Zaks to serve as a member of the Board, effective October 1, 2021

View on SEC.gov

TEVA PHARMACEUTICAL INDUSTRIES LTD filing history →

Source: SEC EDGAR

accession 0001193125-21-258064

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.